Ch05: Red and White Lesions of the Oral Mucosa

More documents

Recommendations

Info

120 Diagnosis and Management of Oral and Salivary Gland Diseases precancerous lesions among dental patients in Saudi Arabia. Community Dent Oral Epidemiol 1985;13(4):247–8. 72. Van Wyk CW. Nicotinic stomatitis of the palate: a clinico-histological study. J Dent Assoc S Afr 1967;22(4):106–11. 73. Pindborg JJ, Mehta FS, Gupta PC, et al. Reverse smoking in Andhra Pradesh, India: a study of palatal lesions among 10,169 villagers. Br J Cancer 1971;25(1):10–20. 74. Mandel ID. Antimicrobial mouthrinses: overview and update. J Am Dent Assoc 1994;125 Suppl 2:2S–10S. 75. Kopczyk RA, Abrams H, Brown AT, et al. Clinical and microbiological effects of a sanguinaria-containing mouthrinse and dentifrice with and without fluoride during 6 months of use. J Periodontol 1991;62(10):617–22. 76. Hakim SA. Sanguinarine—a carcinogenic contaminant in Indian edible oils. Indian J Cancer 1968;5(2):183–97. 77. Sen A, Ray A, Maiti M. Thermodynamics of the interactions of sanguinarine with DNA: influence of ionic strength and base composition. Biophys Chem 1996;7:59(1–2):155–70. 78. Damm DD, Curran A, White DK, Drummond JF. Leukoplakia of the maxillary vestibule—an association with Viadent? Oral Surg Oral Med Oral Pathol 1999;87(1):61–6. 79. Eversole LR, Eversole GM, Kopcik J. Sanguinaria-associated oral leukoplakia: comparison with other benign and dysplastic leukoplakic lesions. Oral Surg Oral Med Oral Pathol 2000;89(4):455–64. 80. Allen CM. Viadent-related leukoplakia—the tip of the iceberg? Oral Surg Oral Med Oral Pathol 1999;87(4):393–4. 81. Reichart PA, Langford A, Gelderblom HR, et al. Oral hairy leukoplakia: observations in 95 cases and review of the literature. J Oral Pathol Med 1989;18(7):410–5. 82. Greenspan D, Greenspan JS. Oral manifestations of human immunodeficiency virus infection. Dent Clin North Am 1993;37(1):21–32. 83. Greenspan D, Greenspan JS, Hearst NG, et al. Relation of oral hairy leukoplakia to infection with the human immunodeficiency virus and the risk of developing AIDS. J Infect Dis 1987;155(3):475–81. 84. Felix DH, Jalal H, Cubie HA, et al. Detection of Epstein-Barr virus and human papillomavirus type 16 DNA in hairy leukoplakia by in situ hybridisation and the polymerase chain reaction. J Oral Pathol Med 1993;22(6):277–81. 85. Mabruk MJ, Flint SR, Toner M, et al. Detection of Epstein-Barr virus DNA in tongue tissues from AIDS autopsies without clinical evidence of oral hairy leukoplakia. J Oral Pathol Med 1995;24(3):109–12. 86. Mabruk MJ, Flint SR, Toner M, et al. In situ hybridization and the polymerase chain reaction (PCR) in the analysis of biopsies and exfoliative cytology specimens for definitive diagnosis of oral hairy leukoplakia (OHL). J Oral Pathol Med 1994;23(7):302–8. 87. Syrjanen S, Laine P, Niemela M, Happonen RP. Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general. J Oral Pathol Med 1989;18(1):28–31. 88. King GN, Healy CM, Glover MT, et al. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 1994;78(6):718–26. 89. Schiodt M, Norgaard T, Greenspan JS. Oral hairy leukoplakia in an HIV-negative woman with Behcet’s syndrome. Oral Surg Oral Med Oral Pathol 1995;79(1):53–6. 90. Lozada-Nur F, Robinson J, Regezi JA. Oral hairy leukoplakia in nonimmunosuppressed patients. Report of four cases. Oral Surg Oral Med Oral Pathol 1994;78(5):599–602. 91. Eisenberg E, Krutchkoff D, Yamase H. Incidental oral hairy leukoplakia in immunocompetent persons. A report of two cases. Oral Surg Oral Med Oral Pathol 1992;74(3):332–3. 92. Epstein JB, Fatahzadeh M, Matisic J, Anderson G. Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia. Oral Surg Oral Med Oral Pathol 1995;79(5):564–9. 93. Kratochvil FJ, Riordan GP, Auclair PL, et al. Diagnosis of oral hairy leukoplakia by ultrastructural examination of exfoliative cytologic specimens. Oral Surg Oral Med Oral Pathol 1990;70(5):613–8. 94. Mabruk MJ, Flint SR, Coleman DC, et al. A rapid microwavein situ hybridization method for the definitive diagnosis of oral hairy leukoplakia: comparison with immunohistochemistry. J Oral Pathol Med 1996;25(4):170–6. 95. Green TL, Greenspan JS, Greenspan D, De Souza YG. Oral lesions mimicking hairy leukoplakia: a diagnostic dilemma. Oral Surg Oral Med Oral Pathol 1989;67(4):422–6. 96. Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis 1987;8:1543. 97. Krogh P, Holmstrup P, Vedtofte P, Pindborg JJ. Yeast organisms associated with human oral leukoplakia. Acta Derm Venerol Suppl (Stockh) 1986;121:51–5. 98. Barrett AW, Kingsmill UT, Speight PM. The frequency of fungal infection of oral mucosal lesions. Oral Dis 1998;4(1):26–31. 99. Cawson RA. Leukoplakia and oral cancer. Proc R Soc Med 1969;62:610. 100. Kozinn PJ, Taschdjian CL, Wiener H. Incidence and pathogenesis of neonatal candidiasis. Pediatrics 1958;21:421. 101. Epstein JB, Pearsall NN, Truelove EL. Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J Clin Microbiol 1980;12:475. 102. Santarpia RP, Pollock JJ, Renner RP, Spiechowitz E. An in vivo replica method for site-specific detection of Candida albicans on the denture surface in denture stomatitis patients: correlation with clinical disease. J Prosthet Dent 1990;63:437. 103. Guggenheimer J, Moore PA, Rossie, K, et al. Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II Prevalence and characteristics of Candida and candidal lesions. Oral Surg Oral Med Oral Pathol 2000;89(5):570-6. 104. Bud FZ, Jorgensen E, Mojon P, et al. Effects of an oral health program on the occurrence of oral candidiasis in a long-term care facility. Community Dent Oral Epidemiol 2000;28(2):141–9. 105. Reichart PA. [Infections of the oral mucosa II. Bacteria, mycotic and viral infections.] Mund Kiefer Gesichtschir 1999;3(6):298–308. 106. Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization or candidiasis. J Dent Res 1995; 74(5):1152–61. 107. Olsen I. Oral adhesion of yeasts. Acta Odontol Scand 1990;48:45. 108. Darwazeh AMG, Lamey PJ, Samaranayake LP, et al. The relationship between colonization, secretor status and in vitro adhesion of Candida albicans to buccal epithelial cells from diabetics. J Med Microbiol 1990;33:43. 109. Fernanado PH, Panagoda GJ, and Samaranayake LE. The relationship between the acid and alkaline phosphatase activity and the adherence of clinical isolates of Candida parapsiposis to human buccal epithelial cells. APMIS 1999;107(11):1034–42.
Red and White Lesions of the Oral Mucosa 121 110. Tsang CS, Samaranayake LE. Factors affecting the adherence of Candida albicans to human buccal epithelial cells in human immunodeficiency virus infection. Br J Dermatol 1999; 141(5):852–8. 111. Kulak Y, Arikan A, Kazazoglu E. Existence of Candida albicans and microorganisms in denture stomatitis patients. J Oral Rehabil 1997;24(10):780–90. 112. McMullan-Vogel CG, Jude HD, Ollert MW,Vogel CW. Serotype distribution and secretory proteinase activity of Candida albicans isolated from the oral mucosa of patients with denture stomatitis. Oral Microbiol Immunol 1999;14(3):183–9. 113. Reichart PA, Geldesblom HR, Becker J, Kuntz A. AIDS and the oral cavity. The HIV infection, virology, aetiology, immunology, precautions and clinical observations in 100 patients. Int J Oral Maxillofac Surg 1987;16:129. 114. Newton AV. Denture sore mouth. Br Dent J 1962;112:357. 115. Bergendahl T, Issacson G. Effect of nystatin in the treatment of denture stomatitis. Scand J Dent Res 1980;88:446. 116. Davenport J. The oral distribution of Candida in denture stomatitis. Br Dent J 1970;129:151. 117. Cawson RA, Lehner T. Chronic hyperplastic candidiasis-candidal leukoplakia. Br J Dermatol 1968;80:9. 118. Burkhardt A, Seifert G. Morphologische klassification den oralen leukoplakien. Dtsch Med Wochenschr 1977;102:223–9. 119. Pindborg JJ. Oral cancer and precancer. Bristol, UK: John Wright and Sons, 1980. 120. Walker DM, Arendorf TM. Candidal leukoplakia, chronic multifocal candidiasis and median rhomboid glossitis. In: Samaranayake LP, MacFarlane TW. Oral candidosis. Boston: Wright/Butterworth Scientific; 1990. 121. Banoczy J. Oral leukoplakias. The Hague: Martinus Nijhoff; 1982. 122. Porter SR, Scully C. Chronic mucocutaneous candidosis and related syndromes. In: Samaranayake LP, MacFarlane TW. Oral candidosis. Boston: Wright/Butterworth Scientific; 1990. 123. Rothberg MS, Eisenbud L, Griboff S. Chronic mucocutaneous candidiasis-thymoma syndrome. A case report. Oral Surg Oral Med Oral Pathol 1989;68:411. 124. Dongari-Bagtzoglou A, Wen K, Lamster IB. Candida albicans triggers interleukin-6 and interleukin-8 responses by oral fibroblasts in vitro. Oral Microbiol Immunol 1999;14(6):364–70. 125. Harvey RL, Myers JP. Nosocomial fungemia in a large community hospital. Arch Intern Med 1987;147:2117. 126. Klein RS, Harris CA, Small CB, et al. Oral candidiasis in highrisk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354. 127. Blackwell CC, Aly FZM, James VS, et al. Blood group, secretor status and oral carriage of yeasts among patients with diabetes mellitus. Diabetes Res 1989;12:101. 128. Challacombe SJ. Immunology of oral candidosis. In: Samaranayake LP, MacFarlane TW. Oral candidosis. Boston: Wright/Butterworth Scientific; 1990. 129. Wray D, Felix DH, Cumming CG. Alteration of humoral responses to Candida in HIV infection. Br Dent J 1990;168:326. 130. Epstein JB, Kimura LH, Menard TW, et al. Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Arch Oral Biol 1982;27:469. 131. Klein R, Harris C, Small C, et al. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354–8. 132. Hay RJ. Overview of studies of fluconazole in oropharyngeal candidiasis. Rev Infect Dis 1990;12 Suppl:334. 133. Meyer I, Shklar G. The oral manifestations of acquired syphilis. A study of eighty-one cases. Oral Surg Oral Med Oral Pathol 1967;23(1):45–57. 134. Wong PN. Secondary syphilis with extensive oral manifestations. Aust Dent J 1985;30(1):22–4. 135. Mani NJ. Secondary syphilis initially diagnosed from oral lesions. Report of three cases. Oral Surg Oral Med Oral Pathol 1984;58(1):47–50. 136. Axell T, Pindborg JJ, Smith CJ, van der Waal I. Oral white lesions with special reference to precancerous and tobaccorelated lesions: conclusions of an international symposium held in Uppsala, Sweden, May 18–21 1994. International Collaborative Group on Oral White Lesions. J Oral Pathol Med 1996;25(2):49–54. 137. Bouquot JE. Reviewing oral leukoplakia: clinical concepts for the 1990s. J Am Dent Assoc 1991;122(7):80–2. 138. Payne TF. Why are white lesions white? Observations on keratin. Oral Surg Oral Med Oral Pathol 1975;40(5):652–8. 139. Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977;5(1):69–75. 140. Waldron CA, Shafer WG. Leukoplakia revisited. A clinicopathologic study of 3256 oral leukoplakias. Cancer 1975;36(4): 1386–92. 141. Silverman S Jr, Gorsky M, Kaugars GE. Leukoplakia, dysplasia, and malignant transformation. Oral Surg Oral Med Oral Pathol 1996;82:117. 142. Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53:563–8. 143. Schepman KP, van der Meij EH, Smeele LE, et al. Malignant transformation of oral leukoplakia: a follow-up study of a hospital based population of 166 patients with oral leukoplakia from the Netherlands. Oral Oncol 1998;34:270–5. 144. Lumerman H, Freedman P, Kerpel S. Oral epithelial dysplasia and the development of invasive squamous carcinoma. Oral Surg Oral Med Oral Pathol 1995;79:321–9. 145. Field EA, Field JK, Martin MV. Does Candida have a role in oral epithelial neoplasia? J Med Vet Mycol 1989;27(5):277–94. 146. Sugerman PB, Shillitoe EJ. The high risk human papillomaviruses and oral cancer: evidence for and against a causal relationship. Oral Dis 1997;3:130–47. 147. Hansen LS, Olson JA, Silverman S Jr. Proliferative verrucous leukoplakia. A long-term study of thirty patients. Oral Surg Oral Med Oral Pathol 1985;60(3):285–98. 148. Silverman S Jr, Gorsky M. Proliferative verrucous leukoplakia: a follow-up study of 54 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:154–7. 149. Abbey LM, Kaugars GE, Gunsolley JC, et al. Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol 1995;80:188–91. 150. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin 1995;45:328–51. 151. Warnakulasuriya KAAS, Johnson NW. Sensitivity and specificity of OraScan toluidine blue mouthrinse in the detection of oral cancer and precancer. J Oral Pathol Med 1996;25:97–103. 152. Sciubba JJ. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. J Am Dent Assoc 1999;130:1445–57.
Page 1 and 2: 5 ▼ RED AND WHITE LESIONS OF THE
Page 3 and 4: Red and White Lesions of the Oral M
Page 35: Red and White Lesions of the Oral M
Page 41: Red and White Lesions of the Oral M

Ch05: Red and White Lesions of the Oral Mucosa

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?